Mesa Laboratories Stock Performance
| MLAB Stock | USD 87.25 7.82 9.85% |
On a scale of 0 to 100, Mesa Laboratories holds a performance score of 10. The company secures a Beta (Market Risk) of 1.64, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mesa Laboratories will likely underperform. Please check Mesa Laboratories' treynor ratio, downside variance, kurtosis, as well as the relationship between the value at risk and expected short fall , to make a quick decision on whether Mesa Laboratories' current price movements will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Mesa Laboratories are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent basic indicators, Mesa Laboratories sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 9.85 | Five Day Return 10.42 | Year To Date Return 9.85 | Ten Year Return (3.80) | All Time Return 2.8 K |
Forward Dividend Yield 0.0073 | Payout Ratio | Forward Dividend Rate 0.64 | Dividend Date 2025-12-15 | Ex Dividend Date 2025-11-28 |
1 | Why analysts remain bullish on Mesa Laboratories Inc. stock - Long Setup Detailed Earnings Play Alerts - newser.com | 10/23/2025 |
2 | Mesa Labs Fiscal Q2 Earnings Snapshot | 11/07/2025 |
3 | How big funds are accumulating Mesa Laboratories Inc. stock - July 2025 Chart Watch Free High Return Stock Watch Alerts - newser.com | 11/14/2025 |
4 | Published on 2025-11-17 115934 - newser.com | 11/17/2025 |
5 | Heres Why Mesa Laboratories Can Manage Its Debt Responsibly | 11/26/2025 |
6 | Disposition of 2000 shares by Sullivan John James of Mesa Laboratories subject to Rule 16b-3 | 12/02/2025 |
7 | Mesa Laboratories, Inc. to Release Third Quarter Financial Results for Fiscal Year 2026 on February 3, 2026 - Quiver Quantitative | 12/03/2025 |
| Mesa Laboratories dividend paid on 15th of December 2025 | 12/15/2025 |
8 | Mesa Laboratories Price Target Raised to 83.00 | 12/18/2025 |
| Begin Period Cash Flow | 28.2 M | |
| Total Cashflows From Investing Activities | -4.5 M |
Mesa Laboratories Relative Risk vs. Return Landscape
If you would invest 7,061 in Mesa Laboratories on October 8, 2025 and sell it today you would earn a total of 1,664 from holding Mesa Laboratories or generate 23.57% return on investment over 90 days. Mesa Laboratories is currently generating 0.389% in daily expected returns and assumes 2.9383% risk (volatility on return distribution) over the 90 days horizon. In different words, 26% of stocks are less volatile than Mesa, and 93% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Mesa Laboratories Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mesa Laboratories' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Mesa Laboratories, and traders can use it to determine the average amount a Mesa Laboratories' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1324
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MLAB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Mesa Laboratories is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mesa Laboratories by adding it to a well-diversified portfolio.
Mesa Laboratories Fundamentals Growth
Mesa Stock prices reflect investors' perceptions of the future prospects and financial health of Mesa Laboratories, and Mesa Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mesa Stock performance.
| Return On Equity | -0.0093 | ||||
| Return On Asset | 0.0213 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 608.64 M | ||||
| Shares Outstanding | 5.52 M | ||||
| Price To Earning | 433.94 X | ||||
| Price To Book | 2.46 X | ||||
| Price To Sales | 1.96 X | ||||
| Revenue | 240.98 M | ||||
| Gross Profit | 152.44 M | ||||
| EBITDA | 42.35 M | ||||
| Net Income | (1.97 M) | ||||
| Cash And Equivalents | 43.75 M | ||||
| Cash Per Share | 8.23 X | ||||
| Total Debt | 181.47 M | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 2.90 X | ||||
| Book Value Per Share | 32.38 X | ||||
| Cash Flow From Operations | 46.81 M | ||||
| Earnings Per Share | (0.31) X | ||||
| Market Capitalization | 481.82 M | ||||
| Total Asset | 433.35 M | ||||
| Retained Earnings | (188.94 M) | ||||
| Working Capital | (61.28 M) | ||||
| Current Asset | 10.74 M | ||||
| Current Liabilities | 657 K | ||||
About Mesa Laboratories Performance
By analyzing Mesa Laboratories' fundamental ratios, stakeholders can gain valuable insights into Mesa Laboratories' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Mesa Laboratories has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Mesa Laboratories has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 118.16 | 208.66 | |
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | 0.07 | 0.07 | |
| Return On Equity | (0.01) | (0.01) |
Things to note about Mesa Laboratories performance evaluation
Checking the ongoing alerts about Mesa Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Mesa Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 240.98 M. Net Loss for the year was (1.97 M) with profit before overhead, payroll, taxes, and interest of 152.44 M. | |
| Over 93.0% of the company shares are owned by institutional investors | |
| On 15th of December 2025 Mesa Laboratories paid $ 0.16 per share dividend to its current shareholders | |
| Latest headline from globenewswire.com: LRN STOCK DROP Stride, Inc. Stock Plummets 50 percent after Upgrade Issues Disclosed -- Contact BFA Law about the Securities Fraud Class Action |
- Analyzing Mesa Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mesa Laboratories' stock is overvalued or undervalued compared to its peers.
- Examining Mesa Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Mesa Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mesa Laboratories' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Mesa Laboratories' stock. These opinions can provide insight into Mesa Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Mesa Stock analysis
When running Mesa Laboratories' price analysis, check to measure Mesa Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mesa Laboratories is operating at the current time. Most of Mesa Laboratories' value examination focuses on studying past and present price action to predict the probability of Mesa Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mesa Laboratories' price. Additionally, you may evaluate how the addition of Mesa Laboratories to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |